Pelion Green Future
Pelion Green Future GmbH is a venture capital investment firm established in 2016, with headquarters in Munich, Germany, and New York, USA. The firm specializes in investing in companies and technologies that facilitate the energy transition, focusing on two main areas: Renewable Energy Development and Infrastructure Platforms. Pelion actively supports the development of over 10 Gigawatts of renewable energy through its global platform and partnerships. The firm primarily targets investments in seed-stage, early-stage, and later-stage companies within sectors such as agtech, cleantech, climate tech, and food tech. As a privately funded entity, Pelion positions itself as an entrepreneurial investor and strategic partner, operating across Europe, North America, and Australasia.
Samara is a solar energy company that assists households in transitioning to sustainable energy solutions. The company offers a range of products, including solar panels, batteries, and electric car chargers. By utilizing Samara's services, consumers can significantly reduce their electricity bills, potentially saving up to 70%. The company's focus is on enabling households to gain control over their energy production and consumption, promoting a more efficient and environmentally-friendly energy model. Through these offerings, Samara aims to facilitate the adoption of green energy practices among its clients, helping them meet their individual energy needs while contributing positively to the planet.
Entrix is an optimisation and trading platform for grid-scale battery storage that accelerates the transition towards a clean energy future. Our mission is to enable the most effective use of green energy and to ensure the reliability of the future energy system. We provide state-of-the-art technology and services to both asset owners and potential investors across the globe.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.